AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 247 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $76,877,500 | -51.2% | 955,000 | -51.8% | 2.16% | -45.4% |
| Q4 2023 | $157,675,749 | +5.9% | 1,981,100 | -7.0% | 3.95% | -1.7% |
| Q3 2023 | $148,942,579 | -2.7% | 2,131,100 | 0.0% | 4.02% | -5.9% |
| Q2 2023 | $153,140,846 | +16.5% | 2,131,100 | 0.0% | 4.27% | -11.2% |
| Q1 2023 | $131,446,248 | -2.9% | 2,131,100 | +21.4% | 4.80% | -15.9% |
| Q4 2022 | $135,363,150 | – | 1,755,000 | – | 5.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |